Skip to content

Investigating the effectiveness of positive psychotherapy intervention in breast cancer patients

Investigating the effectiveness of positive psychotherapy on the quality of life and life expectancy of breast cancer patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231019059769N4
Enrollment
70
Registered
2026-01-22
Start date
2026-02-03
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer. Benign neoplasm of breast

Interventions

Intervention 1: Intervention group: In the initial session, the general study process will be explained to the participants. Then, pre-test questionnaires, including tools to measure hope, quality of

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Ability to read and write 2. No drug use according to self-reported information 3. Willingness to participate in the study 4. No history of hospitalization in neurological hospitals 5. No experience of losing loved ones in the last six months 6. No experience of divorce in the last six months 7. Awareness and awareness of the disease-

Exclusion criteria

Exclusion criteria: Exclusion criteria: Physical and mental inability to continue treatment. Drug use during the intervention Not participating in more than two intervention sessions

Design outcomes

Primary

MeasureTime frame
Quality of life and life expectancy. Timepoint: Before, immediately after and one month after the intervention. Method of measurement: Miller's life expectancy questionnaire and Weber and Sherburne's quality of life questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam shygan

Shiraz University of Medical Sciences

roya.jbn3910@gmail.com+98 917 106 2659

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026